Position in OGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$569
-$757 QoQ
Shares Held
95
-48.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS holds $145,518,414 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
38,251 | $45,879,399 | |
| 2 | ABBV |
AbbVie Inc.
|
79,596 | $20,029,536 | |
| 3 | PFE |
Pfizer Inc
|
810,791 | $19,523,846 | |
| 4 | AMGN |
Amgen Inc
|
44,979 | $16,287,794 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
118,671 | $14,992,893 | |
| 6 | JNJ |
Johnson & Johnson
|
44,551 | $11,314,616 | |
| 7 | MRK |
Merck & Co., Inc.
|
74,751 | $9,605,503 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
120,493 | $6,942,806 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $569 | 95 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,326 | 185 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,975 | 185 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $919 | 95 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,414 | 95 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,417 | 95 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,817 | 95 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,966 | 95 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,895 | 154 | Shares | Defined | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||